Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France.
Fiche publication
Date publication
juillet 2021
Journal
EBioMedicine
Auteurs
Membres identifiés du Cancéropôle Est :
Mme LOMAZZI Sandra
Tous les auteurs :
Woudenberg T, Pelleau S, Anna F, Attia M, Donnadieu F, Gravet A, Lohmann C, Seraphin H, Guiheneuf R, Delamare C, Stefic K, Marlet J, Brochot E, Castelain S, Augereau O, Sibilia J, Dubos F, Meddour D, Guen CG, Coste-Burel M, Imbert-Marcille BM, Chauvire-Drouard A, Schweitzer C, Gatin A, Lomazzi S, Joulié A, Haas H, Cantais A, Bertholon F, Chinazzo-Vigouroux MF, Abdallah MS, Arowas L, Charneau P, Hoen B, Demeret C, Werf SV, Fontanet A, White M
Lien Pubmed
Résumé
Children are underrepresented in the COVID-19 pandemic and often experience milder disease than adolescents and adults. Reduced severity is possibly due to recent and more frequent seasonal human coronaviruses (HCoV) infections. We assessed the seroprevalence of SARS-CoV-2 and seasonal HCoV specific antibodies in a large cohort in north-eastern France.
Mots clés
COVID-19, SARS-CoV-2, antibody response, seasonal coronaviruses, sero-epidemiology, seroprevalence
Référence
EBioMedicine. 2021 Jul 22;70:103495